Dec 26, 2008
Teva Neuroscience Launching New Needle for Copaxone
Teva Neuroscience has announced the launch of a new, thinner, 29-gauge pre-filled syringe for Copaxone. The company reported that a recent survey of 562 MS patients found the new thinner needle was significantly preferred by 77 percent of patients over the previous 27-gauge needle, and that approximately two out of three (66 percent) participants experienced less pain while using the thinner needle and almost half of the participants (49 percent) had a better experience dealing with injection-site reactions.